Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA DIVIS LABORATORIES ELDER PHARMA/
DIVIS LABORATORIES
 
P/E (TTM) x -1.0 66.0 - View Chart
P/BV x 0.1 7.1 1.4% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 ELDER PHARMA   DIVIS LABORATORIES
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
DIVIS LABORATORIES
Mar-23
ELDER PHARMA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3804,641 8.2%   
Low Rs1882,730 6.9%   
Sales per share (Unadj.) Rs489.2292.6 167.2%  
Earnings per share (Unadj.) Rs-3.268.7 -4.6%  
Cash flow per share (Unadj.) Rs14.481.6 17.7%  
Dividends per share (Unadj.) Rs030.00 0.0%  
Avg Dividend yield %00.8 0.0%  
Book value per share (Unadj.) Rs376.5480.9 78.3%  
Shares outstanding (eoy) m20.54265.47 7.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.612.6 4.6%   
Avg P/E ratio x-89.353.7 -166.4%  
P/CF ratio (eoy) x19.745.2 43.6%  
Price / Book Value ratio x0.87.7 9.8%  
Dividend payout %043.7 -0.0%   
Avg Mkt Cap Rs m5,832978,378 0.6%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1799,750 22.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,04877,675 12.9%  
Other income Rs m2573,447 7.4%   
Total revenues Rs m10,30581,122 12.7%   
Gross profit Rs m2,92123,691 12.3%  
Depreciation Rs m3613,432 10.5%   
Interest Rs m2,75620 14,062.8%   
Profit before tax Rs m6023,686 0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1255,453 2.3%   
Profit after tax Rs m-6518,234 -0.4%  
Gross profit margin %29.130.5 95.3%  
Effective tax rate %209.123.0 908.5%   
Net profit margin %-0.623.5 -2.8%  
BALANCE SHEET DATA
Current assets Rs m9,24097,437 9.5%   
Current liabilities Rs m9,99815,331 65.2%   
Net working cap to sales %-7.5105.7 -7.1%  
Current ratio x0.96.4 14.5%  
Inventory Days Days1288 1,530.8%  
Debtors Days Days602842 71.4%  
Net fixed assets Rs m13,64251,128 26.7%   
Share capital Rs m206531 38.7%   
"Free" reserves Rs m7,528127,140 5.9%   
Net worth Rs m7,733127,671 6.1%   
Long term debt Rs m4,8890-   
Total assets Rs m22,882148,565 15.4%  
Interest coverage x1.01,209.5 0.1%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.40.5 84.0%   
Return on assets %11.812.3 95.7%  
Return on equity %-0.814.3 -5.9%  
Return on capital %22.318.6 120.2%  
Exports to sales %3.185.7 3.6%   
Imports to sales %0.419.8 2.2%   
Exports (fob) Rs m30766,537 0.5%   
Imports (cif) Rs m4315,378 0.3%   
Fx inflow Rs m30766,537 0.5%   
Fx outflow Rs m12515,715 0.8%   
Net fx Rs m18150,822 0.4%   
CASH FLOW
From Operations Rs m11,75424,597 47.8%  
From Investments Rs m-561-27,076 2.1%  
From Financial Activity Rs m-6,762-7,972 84.8%  
Net Cashflow Rs m5,466-10,451 -52.3%  

Share Holding

Indian Promoters % 25.3 51.9 48.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 24.0 36.7 65.3%  
FIIs % 0.0 14.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 74.7 48.1 155.3%  
Shareholders   31,548 354,482 8.9%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Elder Pharma vs Divis Laboratories

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Elder Pharma vs Divis Laboratories Share Price Performance

Period Elder Pharma Divis Laboratories S&P BSE HEALTHCARE
1-Day 4.97% 2.14% 1.18%
1-Month 21.21% -2.15% -0.75%
1-Year -64.54% 22.51% 61.82%
3-Year CAGR -51.65% -1.38% 18.16%
5-Year CAGR -37.46% 15.77% 19.79%

* Compound Annual Growth Rate

Here are more details on the Elder Pharma share price and the Divis Laboratories share price.

Moving on to shareholding structures...

The promoters of Elder Pharma hold a 25.3% stake in the company. In case of Divis Laboratories the stake stands at 51.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Elder Pharma and the shareholding pattern of Divis Laboratories.

Finally, a word on dividends...

In the most recent financial year, Elder Pharma paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Divis Laboratories paid Rs 30.0, and its dividend payout ratio stood at 43.7%.

You may visit here to review the dividend history of Elder Pharma, and the dividend history of Divis Laboratories.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.